The online hub for digital CME and CE courses
The ONA Forum consultants answer your questions
View articles about patient-focused care
Should hydration be administered before all doses of cyclophosphamide (Cytoxan, Neosar) or just for high-dose Cytoxan?
Is bevacizumab (Avastin) use in patients with metastatic colorectal cancer (mCRC) or non-small cell lung cancer (NSCLC) related to a higher incidence of thromboembolic events?
I am concerned about some of our patients with advanced cancer being full code. Is it within my scope to address this with patients, and if so, what is the best approach?
How do certain chemotherapy agents make tumors more radiosensitive?
Is CYP2D6 genotyping for tamoxifen (Nolvadex) sensitivity before use of the drug beneficial?
Where does the use of specialty pharmacies fit into cancer care?
How soon should the creatinine be measured when dosing carboplatin (Paraplatin)?
Is there an evidence-based booklet on cancer and diet available for patients undergoing chemotherapy? Is there any evidence that sugar causes cancer?
What are the two most important ingredients to look for in sunscreen?
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |
